Results from Episealer® Knee multicentre study submitted
Episurf Medical (NASDAQ: EPISB) today announces that the company has been informed by the authors about the submission to a scientific journal of the manuscript “Patient-specific metal implants for focal chondral and osteochondral lesions in the knee – Excellent clinical results at 2 years”. This manuscript covers results from a European multicentre study of the Episealer® Knee implant with 75 patients. “This is wonderful news, and we are incredibly happy. We are now looking forward to seeing this paper published. The size of the study is several times larger than anything previously